Pulmonary Function Testing Systems Market Statistics Insights 2028
The pulmonary function testing systems market size is expected to reach US$ 401.83 million by 2028 from US$ 274.10 million in 2022. The pulmonary function testing systems market is estimated to record a CAGR of 6.6% from 2022 to 2028.
Pulmonary functioning testing (PFT) is a set of noninvasive tests used to measure how well a patient’s lungs are working. These tests are important in diagnosing and treating those with respiratory diseases. In order to perform the tests and obtain accurate results, it is important to use the right types of PFT equipment and machines. The pulmonary functioning testing system is made up of several devices that are used to measure different aspects of lung function. This can include how well the lungs take in and expel air, how efficiently they transfer oxygen to the blood, and how much air they can hold. PFTs measure lung volumes, capacities, and the amount of gas exchange. The rising incidence of lung-related disorders and occupational lung diseases is contributing to the growing pulmonary function testing systems market size. However, the risk of cross-contamination and the lack of skilled professionals are hampering the market growth.
The pulmonary function testing systems market has been segmented based on type, test type, component, application, end user, and geography. In terms of geography, the market is primarily segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing parameters such as pulmonary function testing systems market trends, technological advancements, market dynamics, and the competitive landscape analysis of leading market players.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pulmonary Function Testing Systems Market: Strategic Insights
Market Size Value in US$ 274.10 million in 2022 Market Size Value by US$ 401.83 million by 2028 Growth rate CAGR of 6.6% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Pulmonary Function Testing Systems Market: Strategic Insights
| Market Size Value in | US$ 274.10 million in 2022 |
| Market Size Value by | US$ 401.83 million by 2028 |
| Growth rate | CAGR of 6.6% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Rising Incidence of Lung-Related Disorders
According to the British Lung Foundation 2023 report, ~10,000 people in the UK are newly diagnosed with lung disease every week. Additionally, lung diseases account for more than 70,00,000 hospital admissions, with 6 million inpatient bed-days in the UK annually. Therefore, pulmonary function testing (PFT) systems prove useful in diagnosing and monitoring. The PFT systems provide accurate results, particularly lung volume, capacity, rates of flow, and gas exchange. Additionally, PFT systems utilization assists in assessing treatment for asthma, emphysema, and other chronic lung problems. Through the assessment of lung volumes, capacities, rates of flow, and gas exchange, PFTs can provide information that can be evaluated by physicians to help diagnose certain lung disorders effectively and decide the right treatment for patients. Further, PFTs are noninvasive procedures and are usually recommended by physicians for patients with no hospital stay. Commercial pulmonary function testing systems available in the market include spirometry. Spirometry testing is useful for determining if the patient is suffering from lung disease, type of lung disease, progression of the lung disease, and impairment of lung disease. Spirometry measures airflow and can evaluate a broad range of lung diseases among patients. Thus, the rising incidence of lung-related disorders is fueling the use of pulmonary function testing systems.
Type-Based Insights
Based on type, the pulmonary function testing systems market is segmented into cart-based PFT systems and stationary PFT systems. The cart-based segment held a larger share of the market in 2022. Moreover, the cart-based segment is anticipated to register a higher CAGR in the market during the forecast period.
Test Type-Based Insights
In terms of test type, the pulmonary function testing systems market has been segmented into spirometry, lung volume, gas exchange testing, maximal voluntary ventilation, oxygen titration tests, and others. The spirometry segment held the largest share of the market in 2022. Moreover, the lung volume segment is anticipated to register the highest CAGR in the market during the forecast period.
Component-Based Insights
Based on component, the pulmonary function testing systems market has been segmented into hardware, software, and services. The hardware segment held the largest share of the market in 2022. The software segment is anticipated to register the highest CAGR in the market during the forecast period.
Application-Based Insights
Based on application, the pulmonary function testing systems market has been segmented into chronic obstructive pulmonary disease (COPD), asthma, chronic shortness of breath, restrictive lungs diseases, and others. The chronic obstructive pulmonary disease (COPD) segment held the largest share of the market in 2022. Moreover, the same segment is anticipated to register the highest CAGR in the market during the forecast period.
End User-Based Insights
Based on end user, the pulmonary function testing systems market has been segmented into hospitals, specialty clinics, and diagnostic centers. The hospitals segment held the largest share of the market in 2022. The specialty clinics segment is anticipated to register the highest CAGR in the market during the forecast period.
COVID-19 is a respiratory system infection that may rapidly cause pneumonia-like symptoms and chest infections. This may result in lowering the health conditions of the patient. The ventilators help manage the gas exchange of the patients. Due to the COVID-19 outbreak, there was a very high demand for pulmonary function testing systems. American Lung Association and Centers for Disease Control and Prevention recommended that patients with mild symptoms of COVID-19 carry out pulmonary function testing to check the lung capacity of the patient. Pulmonary function testing is an ideal tool for assessing the physiological impact of a virus that largely attacks the cardiopulmonary system. The technology measuring airflow, lung volumes, and the ability for oxygen and carbon dioxide to transfer between the alveoli and the bloodstream are well established, and facilities to perform these tests are found around the US.
Companies in the pulmonary function testing systems market commonly adopt product launches and expansion strategies to expand their footprint across the world and meet the growing demand. Their focus on product innovation allows them to cater to changing customer demands and maintain their brand name across the globe.
- In June 2022, ndd Medical Technologies (ndd) updated the entire EasyOne product range, including the EasyOne Air, Easy on-PC, EasyOne Pro, and EasyOne Pro LAB, to be compliant with the ATS/ERS Standardization of Spirometry 2019.
- In April 2021, Vyaire Medical announced the European launch of ArtiQ.PFT, an automated tool driven by artificial intelligence that instantly interprets pulmonary function tests (PFTs). ArtiQ.PFT is the first cloud-based PFT solution that leverages artificial intelligence.
In terms of geography, the global pulmonary function testing systems market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Pulmonary Function Testing Systems Market Report Scope
Company Profiles
- COSMED Srl
- MGC Diagnostics Corp
- Morgan Scientific Inc
- Minato Medical Science Co Ltd
- Schiller AG
- Chest MI Inc
- Vyaire Medical Inc
- ndd Medical Technologies Inc
- PulmOne Advanced Medical Devices Ltd
- KoKo PFT Ltd
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Test Type, Component, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
COSMED Srl, MGC Diagnostics Corp, Morgan Scientific Inc, Minato Medical Science Co Ltd, Schiller AG, Chest MI Inc, Vyaire Medical Inc, ndd Medical Technologies Inc, PulmOne Advanced Medical Devices Ltd, KoKo PFT Ltd, and among others are among the leading companies operating in the pulmonary function testing systems market.
Global pulmonary function testing systems market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.
Hospitals segment dominated the global pulmonary function testing systems market and accounted for the largest market share during the forecast period of 2022-2028.
Based on the application, chronic obstructive pulmonary disorder segment took the forefront leaders in the worldwide market by accounting largest share in 2021.
Based on type segment, the cart-based PFT systems segment took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.
Rising incidence of lung-related disorders and occupational lung diseases are the most significant factors responsible for the overall market growth.
Pulmonary functioning testing (PFT) is a set of noninvasive tests that are used to measure how well a patient’s lungs are working. This is important in the diagnosis and treatment of those with respiratory diseases. In order to perform the tests and obtain accurate results, it is important to use the right types of PFT equipment and machines. There are several different devices in system. Pulmonary functioning testing system is made up of several devices that are used to measure different aspects of lung function. This can include how well the lungs take in and expel air, how efficiently they transfer oxygen to the blood, and how much air the lungs can hold. PFT’s measure lung volumes, capacities, and the amount of gas exchange.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Pulmonary Function Testing Systems Market – By Type
1.3.2 Global Pulmonary Function Testing Systems Market – By Test Type
1.3.3 Global Pulmonary Function Testing Systems Market – By Component
1.3.4 Global Pulmonary Function Testing Systems Market – By Application
1.3.5 Global Pulmonary Function Testing Systems Market – By End User
1.3.6 Global Pulmonary Function Testing Systems Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Pulmonary Function Testing Systems Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East and Africa PEST Analysis
4.3 Experts’ Opinion
5. Pulmonary Function Testing Systems Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Lung-Related Disorders
5.1.2 Occupational Lung Diseases
5.2 Market Restraints
5.2.1 Risk of Cross-Contamination and Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Home Healthcare Pulmonary Function Testing Systems
5.4 Future Trends
5.4.1 Technological Advancements in Pulmonary Function Testing Systems
5.5 Impact Analysis
6. Pulmonary Function Testing Systems Market– Global Analysis
6.1 Global Pulmonary Function Testing Systems Market Revenue Forecast and Analysis
6.2 Global Pulmonary Function Testing Systems Market Revenue Forecast and Analysis
6.3 Market Positioning of Key Players
6.3.1.1 MGC Diagnostics
6.3.1.2 Vyaire Medical Inc
7. Pulmonary Function Testing Systems Market Analysis – By Type
7.1 Overview
7.2 Pulmonary Function Testing Systems Market, By Type, 2021 & 2028 (%)
7.3 Cart-Based PFT Systems
7.3.1 Overview
7.3.2 Cart-Based PFT Systems: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Stationary PFT Systems
7.4.1 Overview
7.4.2 Stationary PFT Systems: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8. Pulmonary Function Testing Systems Market Analysis – By Test Type
8.1 Overview
8.2 Pulmonary Function Testing Systems Market, By Test Type, 2021 & 2028 (%)
8.3 Spirometry
8.3.1 Overview
8.3.2 Spirometry: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.4 Lung Volume
8.4.1 Overview
8.4.2 Lung Volume: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.5 Gas Exchange Testing
8.5.1 Overview
8.5.2 Gas Exchange Testing: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.6 Maximal Voluntary Ventilation
8.6.1 Overview
8.6.2 Maximal Voluntary Ventilation: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.7 Oxygen Titration Test
8.7.1 Overview
8.7.2 Oxygen Titration Test: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
8.8 Others Test
8.8.1 Overview
8.8.2 Others: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
9. Pulmonary Function Testing Systems Market Analysis – By Component
9.1 Overview
9.2 Pulmonary Function Testing Systems Market, By Component, 2021 & 2028 (%)
9.3 Hardware
9.3.1 Overview
9.3.2 Hardware: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
9.4 Software
9.4.1 Overview
9.4.2 Software: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
9.5 Services
9.5.1 Overview
9.5.2 Services: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10. Pulmonary Function Testing Systems Market Analysis – By Application
10.1 Overview
10.2 Pulmonary Function Testing Systems Market, By Application, 2021 & 2028 (%)
10.3 Chronic Obstructive Pulmonary Disease
10.3.1 Overview
10.3.2 Chronic Obstructive Pulmonary Disease: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10.4 Asthma
10.4.1 Overview
10.4.2 Asthma: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10.5 Chronic Shortness of Breath
10.5.1 Overview
10.5.2 Chronic Shortness of Breath: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10.6 Restrictive Lung Disease
10.6.1 Overview
10.6.2 Restrictive Lung Disease: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
11. Pulmonary Function Testing Systems Market Analysis – By End-User
11.1 Overview
11.2 Pulmonary Function Testing Systems Market, By End-User, 2021 & 2028 (%)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
11.4 Specialty Clinics
11.4.1 Overview
11.4.2 Specialty Clinics: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
11.5 Diagnostic Laboratories
11.5.1 Overview
11.5.2 Diagnostic Laboratories: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
12. Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 – Geographic Analysis
12.1 North America: Pulmonary Function Testing Systems Market
12.1.1 Overview
12.1.2 North America: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.3 North America: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.4 North America: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.5 North America: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.6 North America: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.7 North America: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.1.7.1 US: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.1.1 Overview
12.1.7.1.2 US: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.1.3 US: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.7.1.4 US: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.7.1.5 US: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.7.1.6 US: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.7.1.7 US: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.1.7.2 Canada: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.2.1 Overview
12.1.7.2.2 Canada: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.2.3 Canada: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.7.2.4 Canada: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.7.2.5 Canada: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.7.2.6 Canada: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.7.2.7 Canada: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.1.7.3 Mexico: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.3.1 Overview
12.1.7.3.2 Mexico: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.1.7.3.3 Mexico: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.1.7.3.4 Mexico: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.1.7.3.5 Mexico: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.1.7.3.6 Mexico: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.1.7.3.7 Mexico: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2 Europe: Pulmonary Function Testing Systems Market
12.2.1 Overview
12.2.2 Europe: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.3 Europe: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.4 Europe: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.5 Europe: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.6 Europe: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.7 Europe: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8 Europe: Pulmonary Function Testing Systems Market, by Country, 2021 & 2028 (%)
12.2.8.1 Germany: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.1 Overview
12.2.8.1.2 Germany: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.3 Germany: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.1.4 Germany: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.1.5 Germany: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.1.6 Germany: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.1.7 Germany: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8.2 UK: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.1 Overview
12.2.8.2.2 UK: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.3 UK: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.2.4 UK: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.2.5 UK: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.2.6 UK: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.2.7 UK: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8.3 France: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.1 Overview
12.2.8.3.2 France: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.3 France: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.3.4 France: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.3.5 France: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.3.6 France: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.3.7 France: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8.4 Italy: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.1 Overview
12.2.8.4.2 Italy: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.3 Italy: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.4.4 Italy: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.4.5 Italy: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.4.6 Italy: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.4.7 Italy: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8.5 Spain: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.1 Overview
12.2.8.5.2 Spain: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.3 Spain: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.5.4 Spain: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.5.5 Spain: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.5.6 Spain: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.5.7 Spain: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.2.8.6 Rest of Europe: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.1 Overview
12.2.8.6.2 Rest of Europe: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.3 Rest of Europe: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.2.8.6.4 Italy: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.2.8.6.5 Italy: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.2.8.6.6 Italy: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.2.8.6.7 Italy: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3 Asia Pacific: Pulmonary Function Testing Systems Market
12.3.1 Overview
12.3.2 Asia Pacific: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.3 Asia Pacific: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.4 Asia Pacific: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.5 Asia Pacific: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.6 Asia Pacific: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.7 Asia Pacific: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8 Asia Pacific: Pulmonary Function Testing Systems Market, by Country, 2021 & 2028 (%)
12.3.8.1 China: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.1.1 Overview
12.3.8.1.2 China: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.1.3 China: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.1.4 China: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.1.5 China: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.1.6 China: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.1.7 China: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8.2 Japan: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.2.1 Overview
12.3.8.2.2 Japan: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.2.3 Japan: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.2.4 Japan: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.2.5 Japan: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.2.6 Japan: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.2.7 Japan: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8.3 India: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.3.1 Overview
12.3.8.3.2 India: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.3.3 India: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.3.4 India: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.3.5 India: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.3.6 India: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.3.7 India: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8.4 South Korea: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.4.1 Overview
12.3.8.4.2 South Korea: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.4.3 South Korea: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.4.4 South Korea: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.4.5 South Korea: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.4.6 South Korea: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.4.7 South Korea: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8.5 Australia: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.5.1 Overview
12.3.8.5.2 Australia: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.5.3 Australia: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.5.4 Australia: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.5.5 Australia: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.5.6 Australia: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.5.7 Australia: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.3.8.6 Rest of Asia Pacific: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.6.1 Overview
12.3.8.6.2 Rest of Asia Pacific: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.3.8.6.3 Rest of Asia Pacific: Pulmonary Function Testing Systems Market, by Type, 2019–2028 (US$ Million)
12.3.8.6.4 Rest of Asia Pacific: Pulmonary Function Testing Systems Market, by Test Type, 2019–2028 (US$ Million)
12.3.8.6.5 Rest of Asia Pacific: Pulmonary Function Testing Systems Market, by Component, 2019–2028 (US$ Million)
12.3.8.6.6 Rest of Asia Pacific: Pulmonary Function Testing Systems Market, by Application, 2019–2028 (US$ Million)
12.3.8.6.7 Rest of Asia Pacific: Pulmonary Function Testing Systems Market, by End User, 2019–2028 (US$ Million)
12.4 Middle East & Africa Exoskeleton Robotic System Market
12.4.1 Overview
12.4.2 Middle East & Africa Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.3 Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
12.4.4 Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
12.4.5 Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
12.4.6 Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
12.4.7 Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End Use (US$ Mn)
12.4.8 Middle East & Africa Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Country (%)
12.4.8.1 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.1.1 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.1.2 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
12.4.8.1.3 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
12.4.8.1.4 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
12.4.8.1.5 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
12.4.8.1.6 Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
12.4.8.2 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.2.1 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.2.2 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
12.4.8.2.3 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
12.4.8.2.4 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
12.4.8.2.5 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
12.4.8.2.6 South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
12.4.8.3 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.3.1 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.3.2 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
12.4.8.3.3 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
12.4.8.3.4 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
12.4.8.3.5 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
12.4.8.3.6 UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
12.4.8.4 Rest of Middle East and Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.4.1 Rest of Middle East and Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
12.4.8.4.2 Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
12.4.8.4.3 Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
12.4.8.4.4 Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
12.4.8.4.5 Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
12.4.8.4.6 Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
12.5 South & Central America Pulmonary Function Testing Systems Market
12.5.1 Overview
12.5.2 South & Central America: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.3 South & Central America: Pulmonary Function Testing Systems Market, by Type, 2019-2028 (US$ Million)
12.5.4 South & Central America: Pulmonary Function Testing Systems Market, by Test Type, 2019-2028 (US$ Million)
12.5.5 South & Central America: Pulmonary Function Testing Systems Market, by Component, 2019-2028 (US$ Million)
12.5.6 South & Central America: Pulmonary Function Testing Systems Market, by Application, 2019-2028 (US$ Million)
12.5.7 South & Central America: Pulmonary Function Testing Systems Market, by End-User, 2019-2028 (US$ Million)
12.5.8 South & Central America: Pulmonary Function Testing Systems Market, by Country, 2021 & 2028 (%)
12.5.8.1 Brazil: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.1.1 Brazil: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.1.2 Brazil: Pulmonary Function Testing Systems Market, by Type, 2019-2028 (US$ Million)
12.5.8.1.3 Brazil: Pulmonary Function Testing Systems Market, by Test Type, 2019-2028 (US$ Million)
12.5.8.1.4 Brazil: Pulmonary Function Testing Systems Market, by Component, 2019-2028 (US$ Million)
12.5.8.1.5 Brazil: Pulmonary Function Testing Systems Market, by Application, 2019-2028 (US$ Million)
12.5.8.1.6 Brazil: Pulmonary Function Testing Systems Market, by End-User, 2019-2028 (US$ Million)
12.5.8.2 Argentina: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.2.1 Argentina: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.2.2 Argentina: Pulmonary Function Testing Systems Market, by Type, 2019-2028 (US$ Million)
12.5.8.2.3 Argentina: Pulmonary Function Testing Systems Market, by Test Type, 2019-2028 (US$ Million)
12.5.8.2.4 Argentina: Pulmonary Function Testing Systems Market, by Component, 2019-2028 (US$ Million)
12.5.8.2.5 Argentina: Pulmonary Function Testing Systems Market, by Application, 2019-2028 (US$ Million)
12.5.8.2.6 Argentina: Pulmonary Function Testing Systems Market, by End-User, 2019-2028 (US$ Million)
12.5.8.3 Rest of South & Central America: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.3.1 Rest of South & Central America: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
12.5.8.3.2 Rest of South & Central America: Pulmonary Function Testing Systems Market, by Type, 2019-2028 (US$ Million)
12.5.8.3.3 Rest of South & Central America: Pulmonary Function Testing Systems Market, by Test Type, 2019-2028 (US$ Million)
12.5.8.3.4 Rest of South & Central America: Pulmonary Function Testing Systems Market, by Component, 2019-2028 (US$ Million)
12.5.8.3.5 Rest of South & Central America: Pulmonary Function Testing Systems Market, by Application, 2019-2028 (US$ Million)
12.5.8.3.6 Rest of South & Central America: Pulmonary Function Testing Systems Market, by End-User, 2019-2028 (US$ Million)
13. Impact of COVID-19 Pandemic on Pulmonary Function Testing Market
13.1 North America: Impact Assessment of COVID-19 Pandemic
13.2 Europe: Impact Assessment of COVID-19 Pandemic
13.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
13.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
13.5 South & Central America: Impact Assessment of COVID-19 Pandemic
14. Global Pulmonary Function Testing Systems Market – Industry Landscape
14.1 Overview
14.2 Growth Strategies in Pulmonary Function Testing Systems Market
14.3 Organic Growth Strategies
14.3.1 Overview
14.4 Inorganic Growth Strategies
14.4.1 Overview
15. Company Profiles
15.1 COSMED Srl
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 MGC Diagnostics Corp
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Morgan Scientific Inc
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Minato Medical Science Co Ltd
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Schiller AG
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Chest MI Inc
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Vyaire Medical Inc
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 ndd Medical Technologies Inc
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 PulmOne Advanced Medical Devices Ltd
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 KoKo PFT Ltd
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 9. US Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 10. US Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Europe Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 23. Europe Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 24. Europe Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 25. Europe Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 29. Germany Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 30. Germany Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. UK Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. UK Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 33. UK Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 34. UK Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 35. UK Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 36. France Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 37. France Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 38. France Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 39. France Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 40. France Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 41. Italy Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 42. Italy Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 43. Italy Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 44. Italy Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 45. Italy Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 46. Spain Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 47. Spain Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 48. Spain Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 49. Spain Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 50. Spain Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 51. Rest of Europe Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 52. Italy Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 53. Italy Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 54. Italy Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 55. Italy Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 56. Asia Pacific Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 57. Asia Pacific Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 58. Asia Pacific Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 59. Asia Pacific Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 60. Asia Pacific Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 61. China Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 62. China Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 63. China Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 64. China Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 65. China Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 66. Japan Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 67. Japan Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 68. Japan Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 69. Japan Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 70. Japan Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 71. India Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 72. India Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 73. India Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 74. India Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 75. India Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 76. South Korea Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 77. South Korea Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 78. South Korea Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 79. South Korea Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 80. South Korea Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 81. Australia Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 82. Australia Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 83. Australia Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 84. Australia Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 85. Australia Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 86. Rest of Asia Pacific Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 87. Rest of Asia Pacific Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 88. Rest of Asia Pacific Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (US$ Million)
Table 89. Rest of Asia Pacific Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 90. Rest of Asia Pacific Pulmonary Function Testing Systems Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 91. Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
Table 92. Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
Table 93. Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
Table 94. Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 95. Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End Use (US$ Mn)
Table 96. Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
Table 97. Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
Table 98. Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
Table 99. Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 100. Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 101. South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
Table 102. South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
Table 103. South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
Table 104. South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 105. South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 106. UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
Table 107. UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
Table 108. UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
Table 109. UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 110. UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 111. Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Type (US$ Mn)
Table 112. Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Test Type (US$ Mn)
Table 113. Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Component (US$ Mn)
Table 114. Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Application (US$ Mn)
Table 115. Rest of Middle East & Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 116. South & Central America Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 117. South & Central America Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
Table 118. South & Central America Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (USD Million)
Table 119. South & Central America Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 120. South & Central America Pulmonary Function Testing Systems Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 121. Brazil Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 122. Brazil Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
Table 123. Brazil Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (USD Million)
Table 124. Brazil Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 125. Brazil Pulmonary Function Testing Systems Market, by End-User– Revenue and Forecast to 2028 (USD Million)
Table 126. Argentina Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 127. Argentina Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
Table 128. Argentina Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (USD Million)
Table 129. Argentina Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 130. Argentina Pulmonary Function Testing Systems Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 131. Rest of South & Central America Pulmonary Function Testing Systems Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 132. Rest of South & Central America Pulmonary Function Testing Systems Market, by Test Type – Revenue and Forecast to 2028 (USD Million)
Table 133. Rest of South & Central America Pulmonary Function Testing Systems Market, by Component – Revenue and Forecast to 2028 (USD Million)
Table 134. Rest of South & Central America Pulmonary Function Testing Systems Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 135. Rest of South & Central America Pulmonary Function Testing Systems Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 136. Recent Organic Growth Strategies in Pulmonary Function Testing Systems Market
Table 137. Recent Inorganic Growth Strategies in the Pulmonary Function Testing Systems Market
Table 138. Glossary of Terms
LIST OF FIGURES
Figure 1. Pulmonary Function Testing Systems Market Segmentation
Figure 2. Pulmonary Function Testing Systems Market, By Region
Figure 3. Global Pulmonary Function Testing Systems Market Overview
Figure 4. Cart-Based PFT System Segment Held Largest Share of Type Segment in Pulmonary Function Testing Systems Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Pulmonary Function Testing Systems Market, by Geography (US$ Million)
Figure 7. Global Pulmonary Function Testing Systems Market- Leading Country Markets (US$ Million)
Figure 8. Global Pulmonary Function Testing Systems Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. South & Central America: PEST Analysis
Figure 13. Middle East and Africa: PEST Analysis
Figure 14. Experts’ Opinion
Figure 15. Pulmonary Function Testing Systems Market: Impact Analysis of Drivers and Restraints
Figure 16. Global Pulmonary Function Testing Systems Market– Revenue Forecast and Analysis – 2020- 2028
Figure 17. Global Pulmonary Function Testing Systems Market– Revenue Forecast and Analysis – 2022 - 2028
Figure 18. Market Positioning of Key Players in Global Pulmonary Function Testing Systems Market
Figure 19. Pulmonary Function Testing Systems Market, by Type, 2021 & 2028 (%)
Figure 20. Cart-Based PFT Systems: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Stationary PFT Systems: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Pulmonary Function Testing Systems Market, by Test Type, 2021 & 2028 (%)
Figure 23. Spirometry: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Lung Volume: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Gas Exchange Testing: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Maximal Voluntary Ventilation: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Oxygen Titration Test: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Others: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 29. Pulmonary Function Testing Systems Market, by Component, 2021 & 2028 (%)
Figure 30. Hardware: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 31. Software: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 32. Services: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 33. Pulmonary Function Testing Systems Market, by Application, 2021 & 2028 (%)
Figure 34. Chronic Obstructive Pulmonary Disease: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 35. Asthma: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 36. Chronic Shortness of Breath: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 37. Restrictive Lung Disease: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 38. Others: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 39. Pulmonary Function Testing Systems Market, by End-User, 2021 & 2028 (%)
Figure 40. Hospitals: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 41. Specialty Clinics: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 42. Diagnostic Laboratories: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Million)
Figure 43. North America: Pulmonary Function Testing Systems Market, by Key Country – Revenue (2021) (US$ Million)
Figure 44. North America Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. North America: Pulmonary Function Testing Systems Market, by Country, 2021 & 2028 (%)
Figure 46. US: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Canada: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Mexico: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Europe: Pulmonary Function Testing Systems Market, by Key Country – Revenue (2021) (US$ Million)
Figure 50. Europe Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. Europe: Pulmonary Function Testing Systems Market, by Country, 2021 & 2028 (%)
Figure 52. Germany: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. UK: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. France: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. Italy: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. Spain: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. Rest of Europe: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. Asia Pacific: Pulmonary Function Testing Systems Market, by Key Country – Revenue (2021) (US$ Million)
Figure 59. Asia Pacific Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. China: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. Japan: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 62. India: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 63. South Korea: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. Australia: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 65. Rest of Asia Pacific: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 66. Middle East & Africa Pulmonary Function Testing Systems Market Revenue Overview, by Country, 2021 (US$ Mn)
Figure 67. Middle East & Africa Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 68. Middle East & Africa Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028, By Country (%)
Figure 69. Saudi Arabia: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 70. South Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 71. UAE: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 72. Rest of Middle East and Africa: Pulmonary Function Testing Systems Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 73. South & Central America: Pulmonary Function Testing Systems Market, by Key Country – Revenue (2021) (US$ Million)
Figure 74. South & Central America Pulmonary Function Testing Systems Market Revenue and Forecast to 2028 (US$ Million)
Figure 75. South & Central America: Pulmonary Function Testing Systems Market, by Country, 2021 & 2028 (%)
Figure 76. Brazil: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 77. Argentina: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 78. Rest of South & Central America: Pulmonary Function Testing Systems Market – Revenue and Forecast to 2028 (US$ Million)
Figure 79. Impact of COVID-19 Pandemic on North American Country Markets
Figure 80. Impact of COVID-19 Pandemic in European Country Markets
Figure 81. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 82. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 83. Impact of COVID-19 Pandemic in South & Central America Country Markets
Figure 84. Growth Strategies in Pulmonary Function Testing Systems Market
The List of Companies - Pulmonary Function Testing Systems Market
- SCHILLER
- COSMED srl
- MGC Diagnostics Corporation
- Ganshoran Medizin Electronic
- ndd Medical Technologies
- Morgan Scientific Inc.
- Pulm One Advanced Medical Devices Ltd
- CHEST M.I., Inc
- Vyaire Medical, Inc.
- Koko LLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For